<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>treatment resistant depression Archives - Gateway Psychiatric</title>
	<atom:link href="https://www.gatewaypsychiatric.com/tag/treatment-resistant-depression/feed/" rel="self" type="application/rss+xml" />
	<link></link>
	<description>Excellent Psychiatric Care</description>
	<lastBuildDate>Thu, 24 Jun 2021 13:58:45 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.1</generator>

<image>
	<url>https://i0.wp.com/www.gatewaypsychiatric.com/wp-content/uploads/2013/06/favicon2.png?fit=32%2C32&#038;ssl=1</url>
	<title>treatment resistant depression Archives - Gateway Psychiatric</title>
	<link></link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">70562394</site>	<item>
		<title>Psilocybin-Assisted Supportive Psychotherapy in the Treatment of Major Depression</title>
		<link>https://www.gatewaypsychiatric.com/psilocybin-assisted-supportive-psychotherapy-in-the-treatment-of-major-depression/</link>
					<comments>https://www.gatewaypsychiatric.com/psilocybin-assisted-supportive-psychotherapy-in-the-treatment-of-major-depression/#respond</comments>
		
		<dc:creator><![CDATA[Peter Forster]]></dc:creator>
		<pubDate>Thu, 12 Nov 2020 20:22:00 +0000</pubDate>
				<category><![CDATA[Treatments of Depression]]></category>
		<category><![CDATA[hallucinogens]]></category>
		<category><![CDATA[psilocybin]]></category>
		<category><![CDATA[treatment of depression]]></category>
		<category><![CDATA[treatment resistant depression]]></category>
		<category><![CDATA[treatments of depression]]></category>
		<guid isPermaLink="false">https://www.gatewaypsychiatric.com/?p=17155</guid>

					<description><![CDATA[<p>We have been eagerly awaiting the results of controlled studies of psilocybin treatment of depression (used along with psychotherapy). A large multi-center study is still recruiting participants. Meanwhile a great deal of interest in this topic has been stirred up by Michael Pollan and his book How to Change Your Mind. But clinicians have had very little solid science upon ... </p>
<div><a href="https://www.gatewaypsychiatric.com/psilocybin-assisted-supportive-psychotherapy-in-the-treatment-of-major-depression/" class="more-link">Read More</a></div>
<p>The post <a href="https://www.gatewaypsychiatric.com/psilocybin-assisted-supportive-psychotherapy-in-the-treatment-of-major-depression/">Psilocybin-Assisted Supportive Psychotherapy in the Treatment of Major Depression</a> appeared first on <a href="https://www.gatewaypsychiatric.com">Gateway Psychiatric</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.gatewaypsychiatric.com/psilocybin-assisted-supportive-psychotherapy-in-the-treatment-of-major-depression/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">17155</post-id>	</item>
		<item>
		<title>Treatment Resistant Depression &#8211; More Clues to Predicting Response &#8211; VAST-D</title>
		<link>https://www.gatewaypsychiatric.com/treatment-resistant-depression-more-clues-to-predicting-response-vast-d/</link>
					<comments>https://www.gatewaypsychiatric.com/treatment-resistant-depression-more-clues-to-predicting-response-vast-d/#respond</comments>
		
		<dc:creator><![CDATA[Peter Forster]]></dc:creator>
		<pubDate>Thu, 11 Apr 2019 02:20:36 +0000</pubDate>
				<category><![CDATA[Major Depression]]></category>
		<category><![CDATA[Treatments of Depression]]></category>
		<category><![CDATA[depression treatments]]></category>
		<category><![CDATA[effectiveness]]></category>
		<category><![CDATA[treatment resistant depression]]></category>
		<category><![CDATA[treatments of depression]]></category>
		<guid isPermaLink="false">https://www.gatewaypsychiatric.com/?p=15704</guid>

					<description><![CDATA[<p>Clues that can help us provide more effective care for those with treatment resistant depression are urgently needed. Sidney Zisook and colleagues report an analysis of the data from a large study of veterans with chronic depression (VAST-D) and conclude that two clinical features can help predict likely response to medications changes for some patients who have failed at least ... </p>
<div><a href="https://www.gatewaypsychiatric.com/treatment-resistant-depression-more-clues-to-predicting-response-vast-d/" class="more-link">Read More</a></div>
<p>The post <a href="https://www.gatewaypsychiatric.com/treatment-resistant-depression-more-clues-to-predicting-response-vast-d/">Treatment Resistant Depression &#8211; More Clues to Predicting Response &#8211; VAST-D</a> appeared first on <a href="https://www.gatewaypsychiatric.com">Gateway Psychiatric</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.gatewaypsychiatric.com/treatment-resistant-depression-more-clues-to-predicting-response-vast-d/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">15704</post-id>	</item>
		<item>
		<title>Maintenance TMS</title>
		<link>https://www.gatewaypsychiatric.com/maintenance-tms/</link>
					<comments>https://www.gatewaypsychiatric.com/maintenance-tms/#respond</comments>
		
		<dc:creator><![CDATA[Peter Forster]]></dc:creator>
		<pubDate>Sat, 02 Dec 2017 15:01:55 +0000</pubDate>
				<category><![CDATA[Major Depression]]></category>
		<category><![CDATA[Treatments of Depression]]></category>
		<category><![CDATA[chronic depression]]></category>
		<category><![CDATA[maintenance]]></category>
		<category><![CDATA[tms]]></category>
		<category><![CDATA[treatment of depression]]></category>
		<category><![CDATA[treatment resistant depression]]></category>
		<guid isPermaLink="false">https://www.gatewaypsychiatric.com/?p=14882</guid>

					<description><![CDATA[<p>A patient with treatment resistant depression and an excellent initial response to TMS asked me about the value of maintenance TMS. The question is a reasonable one given what we know generally about the treatment of chronic and/or treatment resistant depression. Almost all of the effective treatments (psychotherapy, medications, ECT, etcetera) have acute and maintenance treatment components. And for all ... </p>
<div><a href="https://www.gatewaypsychiatric.com/maintenance-tms/" class="more-link">Read More</a></div>
<p>The post <a href="https://www.gatewaypsychiatric.com/maintenance-tms/">Maintenance TMS</a> appeared first on <a href="https://www.gatewaypsychiatric.com">Gateway Psychiatric</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.gatewaypsychiatric.com/maintenance-tms/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">14882</post-id>	</item>
		<item>
		<title>TMS Effectiveness Updated</title>
		<link>https://www.gatewaypsychiatric.com/tms-effectiveness-updated/</link>
		
		<dc:creator><![CDATA[Peter Forster]]></dc:creator>
		<pubDate>Mon, 13 Feb 2017 03:22:26 +0000</pubDate>
				<category><![CDATA[Best Practices]]></category>
		<category><![CDATA[Major Depression]]></category>
		<category><![CDATA[Treatments of Depression]]></category>
		<category><![CDATA[bilateral tms]]></category>
		<category><![CDATA[deep tms]]></category>
		<category><![CDATA[tms]]></category>
		<category><![CDATA[treatment resistant depression]]></category>
		<category><![CDATA[treatments of depression]]></category>
		<guid isPermaLink="false">https://www.gatewaypsychiatric.com/?p=12354</guid>

					<description><![CDATA[<p>TMS effectiveness for depression is clear. But now there are more machines for providing TMS and more protocols. Is deep TMS better than regular TMS? &#160;Or is deep TMS just a marketing phrase? A major review article in JAMA Psychiatry updated our understanding of alternatives to the initial protocol for TMS. JAMA Psychiatry is the most prestigious journal in psychiatry, ... </p>
<div><a href="https://www.gatewaypsychiatric.com/tms-effectiveness-updated/" class="more-link">Read More</a></div>
<p>The post <a href="https://www.gatewaypsychiatric.com/tms-effectiveness-updated/">TMS Effectiveness Updated</a> appeared first on <a href="https://www.gatewaypsychiatric.com">Gateway Psychiatric</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">12354</post-id>	</item>
		<item>
		<title>Buprenorphine for Depression &#8211; A Combination Approach</title>
		<link>https://www.gatewaypsychiatric.com/buprenorphine-for-depression-a-combination-approach/</link>
		
		<dc:creator><![CDATA[Peter Forster]]></dc:creator>
		<pubDate>Sat, 13 Feb 2016 20:07:18 +0000</pubDate>
				<category><![CDATA[Major Depression]]></category>
		<category><![CDATA[Treatments of Depression]]></category>
		<category><![CDATA[buprenorphine]]></category>
		<category><![CDATA[depression]]></category>
		<category><![CDATA[opiates]]></category>
		<category><![CDATA[samidorphan]]></category>
		<category><![CDATA[treatment resistant depression]]></category>
		<category><![CDATA[treatments of depression]]></category>
		<guid isPermaLink="false">https://www.gatewaypsychiatric.com/?p=10060</guid>

					<description><![CDATA[<p>While we were in the midst of a seeming epidemic of concern about opiate prescribing and possible overuse of opiates by physicians, it is ironic that we are also seeing a small stream of articles being published about the potential effectiveness of opiate agonists in treating patients with treatment resistant depression. I&#8217;ve been interested in this topic since Enoch Callaway, ... </p>
<div><a href="https://www.gatewaypsychiatric.com/buprenorphine-for-depression-a-combination-approach/" class="more-link">Read More</a></div>
<p>The post <a href="https://www.gatewaypsychiatric.com/buprenorphine-for-depression-a-combination-approach/">Buprenorphine for Depression &#8211; A Combination Approach</a> appeared first on <a href="https://www.gatewaypsychiatric.com">Gateway Psychiatric</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">10060</post-id>	</item>
		<item>
		<title>TMS Cost Effectiveness</title>
		<link>https://www.gatewaypsychiatric.com/tms-cost-effectiveness/</link>
		
		<dc:creator><![CDATA[Peter Forster]]></dc:creator>
		<pubDate>Wed, 11 Nov 2015 16:53:27 +0000</pubDate>
				<category><![CDATA[Costs of Treatment]]></category>
		<category><![CDATA[Treatments of Depression]]></category>
		<category><![CDATA[costs of treatment]]></category>
		<category><![CDATA[depression]]></category>
		<category><![CDATA[tms]]></category>
		<category><![CDATA[treatment of depression]]></category>
		<category><![CDATA[treatment resistant depression]]></category>
		<guid isPermaLink="false">https://www.gatewaypsychiatric.com/?p=9385</guid>

					<description><![CDATA[<p>&#8220;Is TMS Cost-Effective?&#8221; His provocative title of an article just published in psychiatric times which summarizes an Australian pharmaco-economic study. In case you don&#8217;t want to read through the rest of this article, here is the summary: &#8220;Australian researchers compared the cost-effectiveness of rTMS with pharmacotherapy in treatment-resistant patients with MDD (ie, those who have failed at least 2 courses ... </p>
<div><a href="https://www.gatewaypsychiatric.com/tms-cost-effectiveness/" class="more-link">Read More</a></div>
<p>The post <a href="https://www.gatewaypsychiatric.com/tms-cost-effectiveness/">TMS Cost Effectiveness</a> appeared first on <a href="https://www.gatewaypsychiatric.com">Gateway Psychiatric</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">9385</post-id>	</item>
		<item>
		<title>Aripiprazole for Late Life Depression</title>
		<link>https://www.gatewaypsychiatric.com/aripiprazole-late-life-depression/</link>
		
		<dc:creator><![CDATA[Peter Forster]]></dc:creator>
		<pubDate>Sat, 17 Oct 2015 15:42:10 +0000</pubDate>
				<category><![CDATA[Major Depression]]></category>
		<category><![CDATA[Treatments of Depression]]></category>
		<category><![CDATA[aripiprazole]]></category>
		<category><![CDATA[geriatric]]></category>
		<category><![CDATA[late life depression]]></category>
		<category><![CDATA[major depression]]></category>
		<category><![CDATA[treatment resistant depression]]></category>
		<category><![CDATA[treatments of depression]]></category>
		<guid isPermaLink="false">https://www.gatewaypsychiatric.com/?p=9320</guid>

					<description><![CDATA[<p>A study suggests that aripiprazole augmentation may be an effective strategy for treating major depression in older adults. The article has generated a lot of interest because of evidence suggesting that late life major depression may be different from major depression in early adulthood. Cognitive impairment, including memory troubles and trouble with planning and decision making (executive function), seems to ... </p>
<div><a href="https://www.gatewaypsychiatric.com/aripiprazole-late-life-depression/" class="more-link">Read More</a></div>
<p>The post <a href="https://www.gatewaypsychiatric.com/aripiprazole-late-life-depression/">Aripiprazole for Late Life Depression</a> appeared first on <a href="https://www.gatewaypsychiatric.com">Gateway Psychiatric</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">9320</post-id>	</item>
	</channel>
</rss>
